OBTAINING
BEST
VALUE
FROM
SALES
OF
SURPLUS
ESTATE
15. Having identified surplus estate, Treasury guidance
is that it should be sold within 3 years. We looked at whether
the incentives used to encourage Trusts to dispose of surplus
estate protected the public interest and whether Trusts got the
best prices.
(a) Whether incentives to sell surplus estate
protect the public interest
16. Trusts have three main incentives to dispose
of surplus estate. The first is to reduce running costs, for example
maintenance. Second, Trusts can retain some of the proceeds of
sales for re-investment locally. Third, they make savings on capital
charges, comprising depreciation and an interest charge attached
to all property assets. However, a major review of the management
of NHS estate, Sold on Health,[14]
recognised that depreciation charges on surplus estate were usually
low because it was coming to the end of its useful life, and that
rather than retaining proceeds within a Trust, projects in the
local health economy might have greater priority.[15]
17. Trusts are allowed to retain the first £1
million of any sale for re-investment without the Department's
authority, although the investment should be based on a business
case. Following Sold on Health, however, the Department
are introducing "earned autonomy freedoms" to allow
top-performing Trusts to retain the first £5 million of receipts
from property sales. If Trusts are failing, and where private
sector managers are brought in, any proceeds will still be re-invested
in the NHS. If sales net more than these thresholds, the surplus
is available for use within the local health economy, subject
to submission of a business case to the Department. From 2002-03
management of the NHS capital programme will move to 28 Strategic
Health Authorities. This will allow proceeds from sales above
the thresholds to be available for local reinvestment within these
redrawn boundaries.[16]
(b) Getting the right price for properties
that are sold
18. The C&AG found that NHS Trusts and their
agents strove to maximise competition, in accordance with NHS
Estates' guidance, achieving prices in most sales which comfortably
exceeded valuations. Most sales90 per centare made
competitively, sometimes through auctions. This provides assurance
that the market has been tested.[17]
19. An important factor in getting the best price
is having accurate and up to date valuations. Valuations by the
District Valuation Office are also a safeguard against corruption.
However, the Comptroller and Auditor General found that prices
obtained met or exceeded valuations in 95 per cent of cases, and
on average exceeded valuations by 32 per cent. The Department
assured us that they required valuations of all property disposals,
but that these could be affected by a variety of factors. Following
the Comptroller and Auditor General's report, they are looking,
prior to marketing, at having a range of valuations dependent
on what opportunities there are for the estate. If planning consent
is granted or there is another material change during marketing,
they will carry out another valuation. Finally, if marketing takes
longer than six months, they will do another valuation as well.[18]
Where there is potential for further development at a later date,
the NHS introduces clawback into the transaction. NHS Trusts negotiated
clawback in almost 50 per cent of sales by value in sales between
1997-98 and 1999-2000.[19]
Where there are preferred bidders from other parts of the public
sector, they have the right to buy the land at the District Valuer's
valuation.[20]
20. Planning permission can dramatically affect the
value of surplus NHS property. A major site, such as an old mental
asylum set in its own substantial grounds, and involving both
heritage and Green Belt issues, might have a negligible or even
negative value without planning permission, but might be worth
many millions with it, for example for residential schemes.
21. NHS Estates' guidance advises that, where a property
has potential for development, it should normally be sold with
the benefit of planning permission for the alternative use. In
negotiating planning consents and related planning obligations,
applicants must take account of the statutory planning environment,
particularly local development plans and national policies. This
puts a premium on the effective handling of land-use planning
issues with local authority planning departments. However, the
Comptroller and Auditor General found wide variation in involvement
between NHS Trusts and local planning authorities. Over a third
of NHS Trusts created prior to the preparation of the relevant
local authority development plan (and therefore assumed able to
participate in its formulation) indicated that they had not been
involved in the formal consultation process.[21]
22. A prime example of the value of gaining permission
planning is Napsbury Hospital. Without planning permission the
site would have been worth £10 million but with it was valued
at £66 million. However, planning permission was only achieved
after a protracted appeal and considerable cost, which the Department
put at £1.1 million, of which they recovered £300,000.
This case emphasises the need for close liaison with local authorities.
NHS Estates were putting good practice on their website, and had
prepared guidance for local authority officers and NHS Trusts
about the relationship between NHS modernisation and local authority
development plans.[22]
DISPOSAL
OF
THE
RETAINED
ESTATE
23. When NHS Trusts were set up in the early to mid
1990s, properties that were surplus or soon to be surplus were
not transferred to them; instead they were held by NHS Estates
in the so called "retained estate". At its peak, in
1994-95, the retained estate was valued at £1.2 billion.
Since then, NHS Estate has conducted a major programme of annual
disposals. In total £1.2 billion of surplus estate has been
sold, exceeding targets set by the Department and at April 2001
the balance remaining was valued at £600 million, (Figure
2). Since then a further £200 million has been sold.[23]
Figure 2: NHS Estates' disposal programme in the
retained estate has met successive annual targets

24. The retained estate had taken some time to sell,
mainly because some properties had been occupied by Trusts in
the short and medium term. NHS Estates have an incentive to dispose
of the estate as quickly as possible, because maintenance costs
are around £35 million a year.[24]
25. The remaining retained estate is now subject
to a one-off sale through a Public Private Partnership, expected
to be operative in 2002-03. This had been outlined in Sold
on Health and was supported by an independent option appraisal.
The options considered were:
- a one-off sale with a single up front payment;
- a one-off sale through a joint venture with an
initial payment plus future payments when development value was
realised; and
- a combination of the first and third options,
which was the one preferred.
26. The preferred approach also envisaged that the
public private partnership would take over NHS Estates trading
arm "Inventures", which offers paid services including
advice and support for NHS Trusts and other health clients including
bespoke consultancy, property and project services, training and
technical guidance.[25]
27. The Department have placed land and property
requiring development work into a joint venture. The private sector
is taking part in a competitive process and the selected partner
will make an upfront payment and further payments (clawback) linked
to the maximisation of the development value of a property. The
private sector partner will provide development funding and share
the risk, for example the cost and risk of obtaining planning
consent. At the same time, NHS Estates will continue to dispose
of land and property where development potential has already been
achieved. Offers were due to be received in May from four short-listed
consortia and completion of the sale is programmed for Autumn
2002.[26]
28. The proposed public private partnership raises
a question mark over the future of NHS Estates. Following the
quinquennial review of NHS Estates, it will retain its policy
lead and role in the provision of guidance to NHS Trusts. The
Department said it was important to retain central expertise within
the NHS, and NHS Estates will be working closely with NHS organisations
on important estates matters, such as the design of operating
theatres, and how to meet standards for environmental cleanliness.[27]
1 Qs 145-150 Back
2
C&AG's Report, para 1.4 Back
3
ibid, para 1.4 and Figure 2 Back
4
ibid, paras 1.10-1.12 Back
5
ibid, paras 1.5-1.7 Back
6
C&AG's Report The Management of Surplus Property by Trusts
in the NHS in England (HC687, Session 2001-02) Back
7
C&AG's Report, para 1.4 and Figure 2 Back
8
Qs 14, 35, 40, 52-56, 122-127, 151-153 Back
9
C&AG's Report, para 2.7 Back
10
C&AG's Report, paras 2.5, 2.9; Qs 3-6, 13-17, 30-33, 118-121,
192-193 Back
11
C&AG's Report, paras 2.27-2.32; Qs 34-40, 71, 127, 229-231 Back
12
Qs 181-188; Note by the Department of Health at Q181; Ev 24 Back
13
C&AG's Report, paras 3.28-3.29; Qs 170-171 Back
14
Public Sector Productivity Panel and Department of Health, Sold
on Health, May 2000 Back
15
C&AG's Report, para 2.18; Qs 137-141 Back
16
Qs 73-76 Back
17
C&AG's Report, paras 7, 3.2-3.5; Qs 82-84, 131 Back
18
C&AG's Report, paras 8, 3.7; Qs 10, 79-89, 114-116 Back
19
C&AG's Report, paras 3.24-3.27; Q130 Back
20
C&AG's Report, para 3.28; Q130 Back
21
C&AG's Report, paras 2.27-2.30; Qs 45-51 Back
22
Qs 7-9, 78 Back
23
C&AG's Report, paras 1.5-1.6; Q21 Back
24
Qs 18-20, 90-92 Back
25
C&AG's Report, paras 1.5-1.7; Ev 26-27 Back
26
Qs 199, 204-205, 211-219; Ev 27 Back
27
C&AG's Report, para 1.7; Qs 193-196 Back